Лучшие больницы для «Pacemaker Implantation» в Дубай, ОАЭ

The all-inclusive cost of pacemaker implantation in India typically ranges from USD 4,000 to USD 9,000, depending on the device type — a single-chamber pacemaker falls toward the lower end, a dual-chamber (DDD) system in the mid-range, and an advanced leadless or cardiac resynchronisation therapy device (CRT-P) toward the upper end. The same procedure at JCI- and DHA-accredited hospitals in Dubai or Abu Dhabi costs between USD 9,000 and USD 18,000, reflecting the premium infrastructure, hotel-standard private rooms, and higher overhead in the UAE healthcare market. In both destinations, the quoted package from GAF Healthcare typically covers the surgeon and anaesthesiologist fees, the pacemaker device hardware (Medtronic, Abbott, Boston Scientific, or Biotronik), the electrophysiology laboratory and fluoroscopy suite usage, hospital stay (2–4 days), routine post-operative medications, and standard follow-up investigations before discharge. Costs can increase for patients requiring more complex interventions such as His bundle pacing, biventricular CRT-D implantation, or management of procedural complications. GAF Healthcare provides a fully itemised, written cost estimate before any commitment is made.

For an uncomplicated single- or dual-chamber pacemaker implantation, most patients are cleared for international air travel approximately 2–3 weeks after the procedure. The timeline is as follows: patients are typically discharged from hospital on day 3–4 post-implant after a mandatory 24–48 hour telemetry monitoring period, a device interrogation confirming stable electrical parameters, and a chest X-ray confirming lead position. A wound review and repeat device check are performed at 10–14 days post-implant, at which point the incision should be fully healed with no signs of infection or haematoma. A final fit-to-fly assessment — including device interrogation, chest X-ray, and cardiologist sign-off — is completed at approximately 2–3 weeks, after which a formal fit-to-fly letter is issued for the airline. Patients who undergo more complex procedures (CRT implantation, concurrent ablation, or those who experience any complication) may require a longer stay of 3–4 weeks. It is important to note that altitude and cabin pressure do not interfere with modern pacemaker function; however, airport security metal detectors and full-body scanners should be navigated with the pacemaker ID card, and patients should request a manual pat-down rather than prolonged proximity to screening wand devices. GAF Healthcare coordinates all fit-to-fly documentation and communicates directly with the patient's home cardiologist to ensure seamless handover.

Pacemaker implantation is one of the most reliably successful procedures in cardiovascular medicine. At high-volume electrophysiology centres — the category of hospitals exclusively partnered with GAF Healthcare — the procedural success rate (defined as successful device implantation with lead positions meeting all electrical implant criteria in a single operative session) exceeds 98–99%. The vast majority of patients experience immediate resolution of symptomatic bradycardia, with significant improvements in exercise tolerance, syncope-free survival, and quality-of-life scores documented within 4–8 weeks of implantation. The major complication rate (pneumothorax requiring intervention, pocket haematoma requiring evacuation, lead dislodgement requiring repositioning, or device infection requiring extraction) is approximately 1–3% across all transvenous implants at experienced centres, and substantially lower for leadless pacemaker implantation with respect to pocket and lead-related complications. Long-term device reliability is also excellent: modern pacemaker generators have a 10-year failure rate of less than 0.1% when used within manufacturer-specified parameters. Battery longevity is typically 8–15 years depending on pacing percentage and output settings, and generator replacement is a planned, low-risk outpatient procedure. Remote monitoring — standard at all GAF partner hospitals — allows the implanting electrophysiologist to proactively detect any early warning signs of lead or device issues, ensuring that international patients receive the same standard of ongoing surveillance as local patients.